|
We asked 40 pharma leaders, how optimistic are you about revenue growth in 2013?
| Very optimistic |
39% |
Somewhat optimistic |
33% |
| Not optimistic at all |
28% |
 |
|
|
|
|
|
|
|
9 April, 2013
|
| In this Issue |
Six Side Effects of India's Ruling on Glivec
Last week’s decision by India’s Supreme Court to deny a patent for the top-selling oncologic drug Glivec took nearly a decade of litigation to resolve — but the implications in and beyond India are both immediate and lasting. Following is a list of six ‘side effects’ that Pharm Exec thinks are most important ...Read more |
Does the Glivec Decision Makes April Fools of Us?
Critics of the IP system have hailed India’s decision on Glivec as a victory for patients and as likely to improve access to the medicine. Yet the consequences of the ruling are damaging for India’s economy as well as for the process of creating other life-saving treatments that future patients may need, writes Helen Disney ... Read more |
The Keys to Success in Personalized Medicine
Success in an era of personalized medicine will depend on excellence in manufacturing, distribution, collaboration, and Big Data, write Edward Currie and Hellmuth Broda ... Read more
|
Read the New Pharm Exec Global Digest
In the April issue: Pharm Exec’s Brand of the Year; Successful Pull Marketing; Are US and Canadian Healthcare Policies Converging; and Is European Healthcare Failing Patients? ... Read more
|
Putting a Value on Health and Innovation
‘Healthcare policies and trends — do they support the innovative life science sector?’ and ‘Determining patient access to pharmaceuticals in Switzerland and the UK — current challenges and outlook’ are the topics to be discussed by, among others, Dr. Ansgar Hebborn and Gavin Lewis of F. Hoffmann-La Roche at this British–Swiss Chamber of Commerce event to be held in Basel, Switzerland, on 22 April ... Read more
|
The Product Manager's Marketing Handbook
Learn how to create a brand positioning statement, build brand value and turn business information into action. Strategy game planning — a competitive intelligence tool for pharma brand and product managers. Get tips on creating an effective launch plan ... Read more
|
|
|
|
